Martin Voss retweetledi
I love early phase studies evaluating a clear hypothesis, with rich correlatives. Great example from @KotechaMD @MSK_DeptOfMed looking at talazoparib and axitinib in pts with kidney cancer #ASCO24 @MVossMD
English
Martin Voss
2 posts
Martin Voss
@MVossMD
GU Oncologist, Memorial Sloan Kettering Cancer Center, New York @MSKCC
New York, NY Katılım Haziran 2020
45 Takip Edilen313 Takipçiler
Martin Voss retweetledi
Interesting RWD showing superior clinical outcomes in 1L with doublet regimens containing targeted therapy compared to monotherapies in pts with #chromophobe RCC!
@MVossMD @ASCO @OncoAlert #ASCO24
English